Cargando…

Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System

To find the potential reasons for the discrepancies in the drug susceptibility test (DST) of M. tuberculosis isolates, twenty paired isolates with disputed drug susceptibilities to isoniazid (INH) were selected according to the MGIT960 testing and Löwenstein-Jensen (L-J) proportion methods. Their MI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Zaoxian, Sun, Zhaogang, Bai, Dapeng, Xu, Yuhui, Li, Zhiling, Huang, Hairong, Li, Chuanyou, Xu, Shaofa, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433640/ https://www.ncbi.nlm.nih.gov/pubmed/26064938 http://dx.doi.org/10.1155/2015/651980

Ejemplares similares

Mycobacterial heparin-binding haemagglutinin adhesion-induced interferon & antibody for detection of tuberculosis
por: Sun, Zhaogang, et al.
Publicado: (2011)

Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China
por: Xu, Yuhui, et al.
Publicado: (2015)

Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results
por: Ocheretina, Oksana, et al.
Publicado: (2014)

Transbronchial tuberculosis cavity plugging therapy for pulmonary tuberculosis
por: Han, Junfeng, et al.
Publicado: (2021)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China
por: Jia, Hongbing, et al.
Publicado: (2021)

Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
por: Xu, Yuhui, et al.
Publicado: (2017)

The study on the association between Beijing genotype family and drug susceptibility phenotypes of Mycobacterium tuberculosis in Beijing
por: Liu, Yi, et al.
Publicado: (2017)

Identification of Serum microRNA Biomarkers for Tuberculosis Using RNA-seq
por: Zhang, Hongtai, et al.
Publicado: (2014)

Rapid Phenotypic Antimicrobial Susceptibility Testing Using a Coulter Counter and Proliferation Rate Discrepancy
por: Yi, Qiaolian, et al.
Publicado: (2023)

Repeat HIV testing of individuals with discrepant HIV self-test results in Central Uganda
por: Kisa, Rose, et al.
Publicado: (2019)

Utilization of whole genome sequencing for resolution of discrepant Mycobacterium tuberculosis drug susceptibility results: A case report()
por: Realegeno, Susan, et al.
Publicado: (2021)

Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru
por: Solari, L., et al.
Publicado: (2020)

Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa
por: Boeras, Debrah I, et al.
Publicado: (2011)

Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon
por: Noeske, Jürgen, et al.
Publicado: (2012)

The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test Results
por: Joh, Joon-Sung, et al.
Publicado: (2007)

Characterization of Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility phenotypes and Beijing genotype family transmission
por: Liu, Yi, et al.
Publicado: (2018)

Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing
por: Huo, Fengmin, et al.
Publicado: (2020)

Discrepancies in the bilateral intradermal test and serum tests in atopic horses
por: van Damme, Catharina M. M., et al.
Publicado: (2020)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
por: Farooq, Hamzah Z., et al.
Publicado: (2021)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens
por: Ren, Weicong, et al.
Publicado: (2023)

Mycobacterium tuberculosis Genotypes and Drug Susceptibility Test Results from Timor-Leste: A Pilot Study
por: Sarmento, Nevio, et al.
Publicado: (2022)

In vivo evolution of drug-resistant Mycobacterium tuberculosis in patients during long-term treatment
por: Xu, Yuhui, et al.
Publicado: (2018)

Discrepancies of SARS-CoV-2 testing results among patients with total laryngectomy
por: Fabbris, C., et al.
Publicado: (2021)

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment
por: Coronel, J, et al.
Publicado: (2014)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization
por: Wood, Hillary N., et al.
Publicado: (2019)

Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review
por: Yusoof, Kizil A., et al.
Publicado: (2022)

Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan
por: Lee, Pin-Hui, et al.
Publicado: (2019)

Discrepancy between non-invasive prenatal testing result and fetal karyotype caused by rare confined placental mosaicism: A case report
por: Li, Zhen, et al.
Publicado: (2022)

Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China
por: Pang, Yu, et al.
Publicado: (2013)

Association of Mycobacterium tuberculosis infection test results with risk factors for tuberculosis transmission
por: Venkatappa, Thara, et al.
Publicado: (2023)

The association between tuberculin skin test result and active tuberculosis risk of college students in Beijing, China: a retrospective cohort study
por: Cao, Demin, et al.
Publicado: (2019)

Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
por: Bwanga, Freddie, et al.
Publicado: (2009)

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi
por: Zhang, Annie, et al.
Publicado: (2018)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
por: Lam, Eugene, et al.
Publicado: (2014)

Discrepancies between tumor genomic profiling and germline genetic testing
por: Pauley, K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98r51ql0tu6qfufau8cb1t434f